Learn how to use LillyDirect to access the GLP-1s Zepbound and Foundayo, and decide whether LillyDirect, telehealth or another pharmacy route fits your needs.
Eli Lilly and Company (NYSE: LLY), the maker of Foundayo (orforglipron), today announced results from a new analysis showing ...
Zepbound and Mounjaro are brand-name injections with the same active ingredient: tirzepatide. Neither Zepbound nor Mounjaro is available as a generic drug. However, various forms of compounded ...
Zepbound and Ozempic are both once-weekly injections but have different active ingredients. Forbes Advisor breaks down the ...
Patients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market. Analysts expect the pill to be as effective, ...
The study estimated cost differences over time, excluding Zepbound costs, 2 using two established methods. Both approaches yielded, on average, lower monthly healthcare costs with sustained Zepbound ...
Eli Lilly will begin offering its popular new weight-loss drug Zepbound in vials—in addition to standard injection-pen devices—at about half the price of the original for certain doses. To date, ...
The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for ...
At Week 52, Taltz and Zepbound maintained or further improved psoriasis or psoriatic arthritis disease activity from Week 36, when statistically superior improvements ...
Both are once-weekly injections for weight loss, but with different active ingredients. Forbes Advisor breaks down the similarities and differences ...
INDIANAPOLIS, Aug. 31, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced 52-week results from TOGETHER-PsO and TOGETHER-PsA, two novel open-label Phase 3b clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results